Myles Minter
Stock Analyst at William Blair
(1.31)
# 3,316
Out of 4,786 analysts
19
Total ratings
50%
Success rate
-8.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMUX Immunic | Initiates: Outperform | n/a | $1.09 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.00 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $591.87 | - | 2 | Nov 1, 2024 | |
| KRRO Korro Bio | Initiates: Outperform | n/a | $17.41 | - | 1 | Aug 14, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $1.00 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $10.59 | +570.44% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $28.35 | - | 1 | Jul 24, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiates: Outperform | n/a | $484.82 | - | 1 | May 30, 2023 | |
| PRAX Praxis Precision Medicines | Downgrades: Market Perform | n/a | $37.87 | - | 2 | Mar 6, 2023 | |
| LRMR Larimar Therapeutics | Upgrades: Outperform | n/a | $2.15 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $270.02 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $30.17 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.23 | - | 1 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $110.60 | +4.88% | 1 | Feb 24, 2020 |
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $1.09
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.00
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $591.87
Upside: -
Korro Bio
Aug 14, 2024
Initiates: Outperform
Price Target: n/a
Current: $17.41
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.00
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $10.59
Upside: +570.44%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $28.35
Upside: -
Vertex Pharmaceuticals
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $484.82
Upside: -
Praxis Precision Medicines
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $37.87
Upside: -
Larimar Therapeutics
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $2.15
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $270.02
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $30.17
Upside: -
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $110.60
Upside: +4.88%